Dose-Response link between tanning bed use, skin cancer

February 28, 2012
Dose-Response link between tanning bed use, skin cancer

(HealthDay) -- Use of tanning beds, especially in high school and college, is associated with an increased risk of skin cancer, according to a study published online Feb. 27 in the Journal of Clinical Oncology.

Mingfeng Zhang, M.D., from Brigham and Women's Hospital in Boston, and colleagues conducted a prospective observational study of 73,494 female nurses, from 1989 to 2009, to investigate whether the frequency of tanning bed use during high school/college and at ages 25 to 35 correlated with the risk of skin cancer. Models were adjusted for host risk factors, sun exposure behaviors at a young age, and ultraviolet index of residence.

During follow-up, the researchers found that 5,506 nurses were diagnosed with (BCC), 403 with (SCC), and 349 with melanoma. For an incremental increase in use of tanning beds of four times per year during both periods, the multivariable-adjusted hazard ratio (HR) of was 1.15 for BCC (P < 0.001), 1.15 for SCC (P = 0.03), and 1.11 for melanoma (P = 0.13). There was a significantly higher risk of BCC associated with the use of tanning beds more than six times per year compared with no use during high school/college compared with use at ages 25 to 35 (HR, 1.73 versus 1.28; P for heterogeneity < 0.001)

"These findings provide evidence to support warning the public against future use of and enacting state and federal legislation to ban tanning bed use for those under age 18," the authors write.

Explore further: Tanning bed users exhibit brain changes and behavior similar to addicts

More information: Abstract
Full Text

Related Stories

Recommended for you

Scientists block breast cancer cells from hiding in bones

May 25, 2016

Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise ...

Genetic sequencing reveals drug resistance growth

May 25, 2016

The rate at which genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new research led by a Weill Cornell Medicine investigator. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.